BBWI's Q4 International Sales Growth Masks Broader Turnaround Challenges

What happened

Bath & Body Works reported a jump in international sales in Q4, as highlighted in a recent Zacks article. This growth is attributed to accelerated store expansion and signals rising global demand. However, the DeepValue master report indicates that the company is in the midst of a challenging transformation, with comparable sales declining domestically. The new CEO has warned that sales growth may not return until 2027, despite cost-saving initiatives. While international expansion offers a capital-light growth path, it must be viewed against the backdrop of ongoing promotional pressures and execution risks in the core business.

Implication

The international segment's performance could help diversify revenue and reduce dependency on the struggling North American market. However, investors should remain cautious as the overall turnaround is dependent on the success of the 'Consumer First Formula' and cost-saving measures. The valuation at current levels reflects significant skepticism, with the base case implying limited upside until comps stabilize. Early signs from international expansion are positive, but they need to be sustained and scaled to materially impact the bull scenario. Until there is clearer evidence of domestic recovery and effective promotion management, the stock likely remains range-bound with downside risk to the bear case.

Thesis delta

The news reinforces the bull scenario's potential for international growth but does not change the core thesis that BBWI's turnaround is a multi-year process. Investors should monitor international metrics closely, but the primary drivers remain domestic comps, margin improvement, and successful execution of the transformation plan. No fundamental shift in the WAIT rating is warranted, as the risks highlighted in the DeepValue report persist.